![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ZNF208 |
Gene summary for ZNF208 |
![]() |
Gene information | Species | Human | Gene symbol | ZNF208 | Gene ID | 7757 |
Gene name | zinc finger protein 208 | |
Gene Alias | PMIDP | |
Cytomap | 19p12 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | M0QYK4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
7757 | ZNF208 | HCC1 | Human | Liver | HCC | 2.90e-08 | 2.82e+00 | 0.5336 |
7757 | ZNF208 | HCC2 | Human | Liver | HCC | 2.94e-26 | 3.97e+00 | 0.5341 |
7757 | ZNF208 | male-WTA | Human | Thyroid | PTC | 2.12e-07 | 1.42e-01 | 0.1037 |
7757 | ZNF208 | PTC01 | Human | Thyroid | PTC | 2.09e-04 | 1.40e-01 | 0.1899 |
7757 | ZNF208 | PTC04 | Human | Thyroid | PTC | 1.04e-12 | 2.83e-01 | 0.1927 |
7757 | ZNF208 | PTC05 | Human | Thyroid | PTC | 6.87e-11 | 4.08e-01 | 0.2065 |
7757 | ZNF208 | PTC06 | Human | Thyroid | PTC | 2.67e-27 | 6.23e-01 | 0.2057 |
7757 | ZNF208 | PTC07 | Human | Thyroid | PTC | 1.67e-30 | 4.95e-01 | 0.2044 |
7757 | ZNF208 | ATC13 | Human | Thyroid | ATC | 9.45e-20 | 4.74e-01 | 0.34 |
7757 | ZNF208 | ATC5 | Human | Thyroid | ATC | 3.64e-23 | 5.14e-01 | 0.34 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
ZNF208 | END | Thyroid | Healthy | HES5,MIR181A1HG,PIM2, etc. | 2.38e-01 | ![]() |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ZNF208 | SNV | Missense_Mutation | rs765288896 | c.2138N>T | p.Arg713Ile | p.R713I | O43345 | protein_coding | tolerated(0.17) | benign(0.054) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF208 | SNV | Missense_Mutation | novel | c.3146N>T | p.Ala1049Val | p.A1049V | O43345 | protein_coding | tolerated(0.13) | benign(0.015) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF208 | SNV | Missense_Mutation | rs776458776 | c.2702N>G | p.Phe901Cys | p.F901C | O43345 | protein_coding | tolerated(0.2) | possibly_damaging(0.683) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
ZNF208 | SNV | Missense_Mutation | c.1807C>A | p.His603Asn | p.H603N | O43345 | protein_coding | deleterious(0) | probably_damaging(0.985) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
ZNF208 | SNV | Missense_Mutation | novel | c.889G>T | p.Val297Phe | p.V297F | O43345 | protein_coding | tolerated(0.72) | benign(0.031) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ZNF208 | SNV | Missense_Mutation | novel | c.2892N>T | p.Lys964Asn | p.K964N | O43345 | protein_coding | deleterious(0.02) | probably_damaging(0.996) | TCGA-EO-A22X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unspecific | Carboplatin | Complete Response |
ZNF208 | SNV | Missense_Mutation | c.1802N>T | p.Arg601Ile | p.R601I | O43345 | protein_coding | tolerated(0.22) | benign(0.07) | TCGA-EO-A22X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unspecific | Carboplatin | Complete Response | |
ZNF208 | SNV | Missense_Mutation | novel | c.39N>A | p.Phe13Leu | p.F13L | O43345 | protein_coding | tolerated(0.06) | possibly_damaging(0.807) | TCGA-EO-A22X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unspecific | Carboplatin | Complete Response |
ZNF208 | SNV | Missense_Mutation | novel | c.3679N>C | p.Cys1227Arg | p.C1227R | O43345 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-EO-A3AV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | CR |
ZNF208 | SNV | Missense_Mutation | c.2070N>T | p.Glu690Asp | p.E690D | O43345 | protein_coding | deleterious(0.04) | probably_damaging(0.96) | TCGA-EO-A3AV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | CR |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |